BEN AUSPITZ
Profile
First Name
Middle Name
Last Name
Related Companies
Titles
Company Name
Related People
DIRECTOR
DONALD BEEMAN,
DONALD P. BEEMAN,
C. BOYD CLARKE,
J. DONALD DEBETHIZY,
J. DONALD DEBETHIZY, PH.D.,
MARKUS GOEBEL,
MARKUS GOEBEL, M.D., PH.D.,
ROB GOODWIN,
ROBERT GOODWIN,
HIRONORI HOZOJI,
GEORGE KEMBLE,
GEORGE KEMBLE, PH.D.,
LARRY MIKKOLA,
IVOR ROYSTON,
IVOR ROYSTON, M.D.
DIRECTOR
BILL ALISKI,
WILLIAM ALISKI,
JOHN DITTON,
STEVEN JUNGLES,
EMIL KAKKIS,
EMIL D. KAKKIS,
THOMAS KASSBERG,
JOHN KLOCK,
CORDELIA LEONARD,
ERAN NADAV,
SHALINI SHARP,
JENNY SORIANO,
VIMAL SRIVASTAVA,
MARTEN STEEN
DIRECTOR
BRUCE BOOTH,
CHRIS CAIN,
KAREN FERRANTE,
JOHN L. GREEN,
PETER HARWIN,
ARLENE MORRIS,
LIAM RATCLIFFE,
MATTHEW ROS,
JESSICA SACHS,
CHRISTIANA STAMOULIS,
CHARLES WILSON
DIRECTOR
ERRIK ANDERSON,
TIMOTHY ANDERSON,
DAMON BANKS,
VERED BISKER-LEIB,
PIOTR BOBROWICZ,
WILL EDEN,
PHILIP FERNEAU,
CARL GORDON,
JEB LEDELL,
SARA MANNLE,
THOMAS SCHUETZ,
THOMAS J SCHUETZ,
THOMAS J. SCHUETZ,
JONATHAN SHELLER,
STEPHEN SQUINTO,
STEVEN SQUINTO,
BRUCE STEEL,
SCHUETZ THOMAS,
STEVE TREGAY
DIRECTOR
CHARLES ABDALIAN,
CHUCK ABDALIAN,
KAREN BRENNAN,
KLEEM CHAUDHARY,
PETER COLABUONO,
KEITH FLAHERTY,
ALAN FUHRMAN,
COREY GOODMAN,
ART KRIEG,
ARTHUR KRIEG,
ARTHUR A. KRIEG,
ARTHUR M. KRIEG,
BARRY LABINGER,
JON LIEBER,
JONATHAN LIEBER,
DAVID MAURO,
MICHAEL POWELL,
RAMANI VARANASI,
ROBERT WEISSKOFF,
JAMES WOOLDRIDGE,
CHARLES YON
DIRECTOR
PETER BARRETT,
CHARLES BOLTEN,
GEORGE H. CAPPS II,
GEORGE H. CAPPS, II,
THOMAS P. CIRRITO,
RAJESH DEVRAJ,
DAVID W. GRIGGS,
ROBERT W. KARR,
SCOTT SEIWERT,
BRADFORD WILLIAMSON,
MICHAEL YEADON,
MICHAEL A. YEADON
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2026-05-22
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2025-04-02
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2023-06-27
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2019-08-14
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2018-11-28
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2018-11-28
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2015-06-17
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2018-03-15
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
2017-12-22
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2017-06-30
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2017-06-02
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2015-06-17
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2016-04-22
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2015-06-17
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2015-06-10
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2015-04-30
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2014-10-03
D/A
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2013-05-03
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2012-12-18
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2012-07-16
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity, Debt
2012-06-21
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2011-06-16
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2011-06-07
D/A
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2010-04-09
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2010-04-09
D/A
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2008-03-18
